No Detail Found!

Sclerotherapy in the treatment of pyogenic granuloma

Author(s)
Basman M. Fadheel Department of Dermatology and Venereology, College of Medicine, Baghdad University, Baghdad, Iraq.
Ghassan A. Ibrahim Center of Dermatology and Venereology, Medical City, Baghdad, Iraq.
Taha A. Abduljabbar Center of Dermatology and Venereology, Medical City, Baghdad, Iraq.
Abstract
Backgound Pyogenic granuloma would be defined as the benign growth composed of clusters of hyperplastic capillaries divided into lobules by fibromyxoid stroma. The limited therapeutic effect and the high recurrence rates associated with traditional treatment modalities, in addition to large size and occurrence of some lesions in surgically difficult areas necessitate the seek for an alternative therapeutic approach. Sclerotherapy is not routinely reported as an option for treating pyogenic granuloma. Objective To assess the tolerability and efficiency of sclerotherapy (polidocanol solution 3%) in pyogenic granuloma treatment. Methods An open-labeled, interventional therapeutic trial conducted from December 2020 to September 2021. Patients who were diagnosed clinically with PG were enrolled in the study and treated by intralesional injections of polidocanol solution 3%. Results There was significant reduction in the mean of lesion sizes during the second visit when put head-to-head with the first visit, the reduction was also present in the third visit when compared to the first two (P value <0.05). Moreover, nearly 62.5% of patients showed complete resolution during the second visit and the remaining 37.5% resolved completely during the third visit. A significant moderate negative correlation was detected between duration of the lesions and resolution. Other factors, like age, gender, site and sizes of the lesions, didn't have significant impact on response to treatment. Conclusion Sclerotherapy with polidocanol solution 3% is a safe and effective treatment for pyogenic granuloma.
Publication Details
Page(s) 408-415
DOI DOI not available
Published Journal: Journal of Pakistan Association of Dermatologists, Volume: 33, Issue: 2, Year: 2023

Request the full text from PASTIC

Keywords
sclerotherapy, eol&gt;Pyogenic granuloma, Polidocanol
0

Citations

0

Downloads

62

Views